Document is current
Any future updates will be listed below
-
Authors
Redeker, Imke http://orcid.org/0000-0003-3377-2683
Moustakis, Stefan
Tsiami, Styliani
Baraliakos, Xenofon http://orcid.org/0000-0002-9475-9362
Kiefer, David
Andreica, Ioana
Buehring, Björn
Braun, Jürgen http://orcid.org/0000-0002-9156-5095
Kiltz, Uta http://orcid.org/0000-0001-5668-4497
-
Funding
Funding for this research was provided by:
St. Elisabeth Gruppe GmbH
- License Information
-
More Information
Article History
Received: 2 May 2024
Accepted: 24 August 2024
First Online: 4 September 2024
Declarations
:
: The Ethical Committee of the Ruhr-Universität Bochum, Germany, approved the study (reference number 20–6993-BR).
: All authors gave their consent for publication.
: IR, SM, ST none.XB has received grant and research support and consultancy fees from AbbVie (Abbot), Amgen, Centocor, Chugai, MSD, Novartis, Pfizer, UCB and Wyeth.DK has received grant and research support and consultancy fees from AbbVie, BMS, Boehringer Ingelheim, Chugai, Eli Lilly, Galapagos, Janssen, MSD, Novartis, Pfizer, Roche and UCB.IA has received research support, consultancy fees and honoraria from Abbvie, Amgen, AstraZeneca, Chugai, Galapagos, Janssen, Eli Lilly, MSD, Novartis, Pfizer, Sobi, Takkeda and UCB.BB has received research support, consultancy fees and honoraria from GE/Lunar, Kinemed, Janssen, UCB, Lilly, AbbVie, Gilead.JB has received honoraria for talks, advisory boards, paid consultancies and grants for studies from Abbvie (Abbott), Amgen, Baxter, Biogen, BMS, Boehringer, Celgene, Celltrion, Centocor, Chugai, Fresenius, GlaxoSmithKline, Gilead, Hexal, Janssen, Lilly, Medac, MSD (Schering-Plough), Mylan, Mundipharma, Novartis, Pfizer (Wyeth, Hospira), Roche, Sanofi-Aventis and UCB.UK has received grant and research support and consultancy fees from AbbVie, Amgen, Biocad, Biogen, Chugai, Eli Lilly, Fresenius, Gilead, Grünenthal, GSK, Hexal, Janssen, MSD, Novartis, onkowissen.de, Pfizer, Roche, UCB and Viatris.
